Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy

Michael Grovdal; Rasheed Khan; Anni Aggerholm; Petar Antunovic; Jan Astermark; Per Bernell; Lena-Maria Engstroem; Lars Kjeldsen; Olle Linder; Lars Nilsson; Anna Olsson; Jonas Wallvik; Jon Magnus Tangen; Gunnar Oeberg; Sten Eirik Jacobsen; Anna Porwit; Peter Hokland; Eva Helistrom-Lindberg

Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy

Michael Grovdal, Rasheed Khan, Anni Aggerholm, Petar Antunovic, Jan Astermark, Per Bernell, Lena-Maria Engstroem, Lars Kjeldsen, Olle Linder, Lars Nilsson, Anna Olsson, Jonas Wallvik, Jon Magnus Tangen, Gunnar Oeberg, Sten Eirik Jacobsen, Anna Porwit, Peter Hokland, Eva Helistrom-Lindberg

Institutionen för kliniska vetenskaper, Malmö

Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract › Peer review

Originalspråk	engelska
Sidor (från-till)	89-89
Tidskrift	Blood
Volym	112
Nummer	11
Status	Published - 2008
Evenemang	50th Annual Meeting of the American- Society-of-Hematology - San Francisco, CA Varaktighet: 2008 dec. 6 → 2008 dec. 9

Bibliografisk information

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Emergency medicine/Medicine/Surgery (013240200)

Ämnesklassifikation (UKÄ)

Hematologi

Citera det här

Grovdal, M., Khan, R., Aggerholm, A., Antunovic, P., Astermark, J., Bernell, P., Engstroem, L-M., Kjeldsen, L., Linder, O., Nilsson, L., Olsson, A., Wallvik, J., Tangen, J. M., Oeberg, G., Jacobsen, S. E., Porwit, A., Hokland, P., & Helistrom-Lindberg, E. (2008). Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy. Blood, 112(11), 89-89.

@article{a8c692a459694faa95fa7f25a009b877,

title = "Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy",

author = "Michael Grovdal and Rasheed Khan and Anni Aggerholm and Petar Antunovic and Jan Astermark and Per Bernell and Lena-Maria Engstroem and Lars Kjeldsen and Olle Linder and Lars Nilsson and Anna Olsson and Jonas Wallvik and Tangen, {Jon Magnus} and Gunnar Oeberg and Jacobsen, {Sten Eirik} and Anna Porwit and Peter Hokland and Eva Helistrom-Lindberg",

note = "The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Emergency medicine/Medicine/Surgery (013240200); 50th Annual Meeting of the American- Society-of-Hematology ; Conference date: 06-12-2008 Through 09-12-2008",

year = "2008",

language = "English",

volume = "112",

pages = "89--89",

journal = "Blood",

issn = "1528-0020",

publisher = "American Society of Hematology",

number = "11",

}

Grovdal, M, Khan, R, Aggerholm, A, Antunovic, P, Astermark, J, Bernell, P, Engstroem, L-M, Kjeldsen, L, Linder, O, Nilsson, L, Olsson, A, Wallvik, J, Tangen, JM, Oeberg, G, Jacobsen, SE, Porwit, A, Hokland, P & Helistrom-Lindberg, E 2008, 'Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy', Blood, vol. 112, nr. 11, s. 89-89.

Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy. / Grovdal, Michael; Khan, Rasheed; Aggerholm, Anni et al.

I: Blood, Vol. 112, Nr. 11, 2008, s. 89-89.

Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract › Peer review

TY - JOUR

T1 - Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy

AU - Grovdal, Michael

AU - Khan, Rasheed

AU - Aggerholm, Anni

AU - Antunovic, Petar

AU - Astermark, Jan

AU - Bernell, Per

AU - Engstroem, Lena-Maria

AU - Kjeldsen, Lars

AU - Linder, Olle

AU - Nilsson, Lars

AU - Olsson, Anna

AU - Wallvik, Jonas

AU - Tangen, Jon Magnus

AU - Oeberg, Gunnar

AU - Jacobsen, Sten Eirik

AU - Porwit, Anna

AU - Hokland, Peter

AU - Helistrom-Lindberg, Eva

N1 - The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Emergency medicine/Medicine/Surgery (013240200)

PY - 2008

Y1 - 2008

M3 - Published meeting abstract

SN - 1528-0020

VL - 112

SP - 89

EP - 89

JO - Blood

JF - Blood

IS - 11

T2 - 50th Annual Meeting of the American- Society-of-Hematology

Y2 - 6 December 2008 through 9 December 2008

ER -